Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301210 · ClinicalTrials.gov registry record · Phase 1
Assessment of Tramadol as a Treatment for Opioid Addiction
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT00301210: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT00301210 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 9 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301210, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Opioids are one of the most commonly abused drugs among individuals who seek treatment for drug abuse. Thus, it is necessary to develop new treatments for opioid addiction. The purpose of this trial is determine whether tramadol is effective in treating opioid dependent individuals.
Interventions
- DRUG Tramadol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
What the finished NCT00301210 record still lists
NCT00301210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Tramadol is the first listed.
NCT00301210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00301210 about?
NCT00301210 is a clinical study titled "Assessment of Tramadol as a Treatment for Opioid Addiction". Opioids are one of the most commonly abused drugs among individuals who seek treatment for drug abuse. Thus, it is necessary to develop new treatments for opioid addiction. The purpose of this trial is determine whether tramadol is effective in treating opioid dependent individuals.
What is the current status of trial NCT00301210?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2006-01. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00301210?
The interventions under investigation include: Tramadol (DRUG).
Who is sponsoring clinical trial NCT00301210?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00301210's enrollment target sits among peer trials
9 1955th of 2000 higher than 42 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia